Breaking News Instant updates and real-time market news.

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:31
04/23/18
04/23
17:31
04/23/18
17:31

Epizyme down 19% after FDA hold on tazemetostat program at resumption of trade

  • 25

    Apr

EPZM Epizyme
$15.25

-0.65 (-4.09%)

02/01/18
ROTH
02/01/18
INITIATION
Target $24
ROTH
Buy
Epizyme initiated with a Buy at Roth Capital
Roth Capital analyst Jotin Marango started Epizyme with a Buy rating and $24 price target as he believes its lead agent tazemetostat, an inhibitor of the histone methyltrasferase EZH2, has laid out a sufficiently wide clinical footprint, and is sufficiently close to an NDA in several indications, that even his conservative approach of ranking its clinical programs shows that the company still remains undervalued.
02/01/18
02/01/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Epizyme (EPZM) initiated with a Buy at Roth Capital. 2. Take-Two (TTWO) initiated with an Overweight at Morgan Stanley. 3. AMERI Holdings (AMRH) initiated with an Outperform at Northland. 4. Simply Good Foods (SMPl) initiated with a Buy at SunTrust. 5. Zynerba (ZYNE) assumed with a Buy at H.C. Wainwright. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/18
RHCO
03/14/18
NO CHANGE
Target $27
RHCO
Buy
Epizyme price target raised to $27 from $21 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Epizyme to $27, saying the company's Q4 earnings call reiterated expectations of on-track data flow in epithelioid sarcoma registrations / NDA filing later this year, the combo data for DLBCL, and the follicular lymphoma data and registration path in the second half of 2018. Lawson keeps his Buy rating and attributes his price target revision to the treatment's higher probability of success.
04/11/18
JEFF
04/11/18
NO CHANGE
Target $27
JEFF
Buy
Epizyme recent pullback creates attractive risk/reward, says Jefferies
Jefferies analyst Michael Yee believes the recent pullback in shares of Epizyme creates an attractive risk/reward ahead of a "catalyst-rich" 2018. The company's market capitalization could appreciate from less than $1B to $2-$3B over time if data in the second half "starts to play out like we expect," Yee tells investors in a research note. He thinks Epizyme's mixed shelf filing last week has some investors concerned that an equity financing could be possible in the near term. Yee believes, however, that the filing "simply replaces and refreshes" an existing one that has always been on hand as opposed to suggesting the company is getting ready to raise near-term cash. The analyst keeps a Buy rating on the shares with a $27 price target.

TODAY'S FREE FLY STORIES

PH

Parker-Hannifin

$189.44

1.99 (1.06%)

14:10
09/18/18
09/18
14:10
09/18/18
14:10
Options
Hefty premium buying in Parker Hannifin as shares spike »

Hefty premium buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSM

Versum Materials

$35.69

-0.265 (-0.74%)

14:09
09/18/18
09/18
14:09
09/18/18
14:09
Conference/Events
Versum Materials management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

VSM

Versum Materials

$35.69

-0.265 (-0.74%)

14:08
09/18/18
09/18
14:08
09/18/18
14:08
Conference/Events
Versum Materials management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SQ

Square

$87.41

0.54 (0.62%)

14:07
09/18/18
09/18
14:07
09/18/18
14:07
Periodicals
Square may offer investment and savings products, Recode says »

According to Recode, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 19

    Sep

  • 20

    Sep

  • 26

    Sep

14:05
09/18/18
09/18
14:05
09/18/18
14:05
General news
NASDAQ is still pacing gains on Wall Street »

NASDAQ is still pacing…

VUZI

Vuzix

$5.95

0.1 (1.71%)

14:04
09/18/18
09/18
14:04
09/18/18
14:04
Hot Stocks
Vuzix partnering with OnCore Golf for 'enhanced ' AR experiences for golfers »

Vuzix is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ABBV

AbbVie

$95.89

0.52 (0.55%)

14:03
09/18/18
09/18
14:03
09/18/18
14:03
Periodicals
CA regulator intervening in whistleblower suit against AbbVie, Bloomberg says »

California's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAN

Dana

$19.32

-0.1 (-0.51%)

14:00
09/18/18
09/18
14:00
09/18/18
14:00
Options
Dana Inc draws bullish option flow »

Dana Inc draws bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

UA

Under Armour

$17.75

0.08 (0.45%)

, UAA

Under Armour

$19.26

0.16 (0.84%)

13:59
09/18/18
09/18
13:59
09/18/18
13:59
Hot Stocks
NPD data shows Under Armour footwear sales down over 25% in August »

Matt Powell, the Senior…

UA

Under Armour

$17.75

0.08 (0.45%)

UAA

Under Armour

$19.26

0.16 (0.84%)

NKE

Nike

$85.10

1.85 (2.22%)

ADDYY

Adidas

$0.00

(0.00%)

SKX

Skechers

$27.88

0.37 (1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 25

    Sep

  • 27

    Nov

13:50
09/18/18
09/18
13:50
09/18/18
13:50
Options
Bullish option flow on a leveraged bond ETF »

Bullish option flow on a…

CLVS

Clovis

$32.82

0.56 (1.74%)

13:45
09/18/18
09/18
13:45
09/18/18
13:45
Hot Stocks
Clovis, executives charged by SEC with misleading investors about cancer drug »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNM

Unum Group

$38.34

1.92 (5.27%)

13:45
09/18/18
09/18
13:45
09/18/18
13:45
Options
Unum Group call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

13:45
09/18/18
09/18
13:45
09/18/18
13:45
General news
Treasury Option Action: put buying is picking up »

Treasury Option Action:…

TSLA

Tesla

$286.20

-8.58 (-2.91%)

13:40
09/18/18
09/18
13:40
09/18/18
13:40
Periodicals
Tesla's Musk confirms dashcam feature using Autopilot cameras, Electrek says »

Elon Musk has confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

NICE

Nice Systems

$115.89

-0.36 (-0.31%)

13:40
09/18/18
09/18
13:40
09/18/18
13:40
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AKRX

Akorn

$13.40

0.12 (0.90%)

13:35
09/18/18
09/18
13:35
09/18/18
13:35
Options
Akorn put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARCI

Appliance Recycling

$1.14

-0.07 (-5.79%)

13:32
09/18/18
09/18
13:32
09/18/18
13:32
Hot Stocks
Appliance Recycling reports regaining compliance with Nasdaq listing rules »

Appliance Recycling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAVE

Rave Restaurant

$1.26

0.01 (0.80%)

13:32
09/18/18
09/18
13:32
09/18/18
13:32
Hot Stocks
Rave Restaurant Group names Bob Bafundo president »

RAVE Restaurant Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHEF

Chefs' Warehouse

$36.35

0.25 (0.69%)

13:28
09/18/18
09/18
13:28
09/18/18
13:28
Conference/Events
Chefs' Warehouse management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

TSLA

Tesla

$283.24

-11.54 (-3.91%)

13:21
09/18/18
09/18
13:21
09/18/18
13:21
Recommendations
Tesla analyst commentary  »

DOJ, SEC investigations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 29

    Oct

SEAS

SeaWorld

$31.04

-0.145 (-0.47%)

13:20
09/18/18
09/18
13:20
09/18/18
13:20
Options
Size ratio spread in Seaworld as shares slip »

Size ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/18/18
09/18
13:17
09/18/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/18/18
09/18
13:16
09/18/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STL

Sterling Bancorp

$21.95

-0.2 (-0.90%)

13:13
09/18/18
09/18
13:13
09/18/18
13:13
Conference/Events
Sterling Bancorp management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 24

    Sep

  • 29

    Oct

ACBFF

Aurora Cannabis

$0.00

(0.00%)

13:13
09/18/18
09/18
13:13
09/18/18
13:13
Hot Stocks
Aurora Cannabis reports additional supply arrangements with Canadian provinces »

Aurora Cannabis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.